| http://www.w3.org/ns/prov#value | - In the accompanying commentary, Drs. Jason Fish and Myron Cybulsky from the University of Toronto note that microRNAs, such as miR-181b, may be exciting and attractive targets for future vascular inflammatory disease therapeutics.Provided by Brigham and Women's Hospital A boost in microRNA may protect against sepsis and other inflammatory diseases.
|
